Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 9861025)

1.

Tumor suppressors TSC1 and TSC2 differentially modulate actin cytoskeleton and motility of mouse embryonic fibroblasts.

Goncharova EA, James ML, Kudryashova TV, Goncharov DA, Krymskaya VP.

PLoS One. 2014 Oct 31;9(10):e111476. doi: 10.1371/journal.pone.0111476. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0118637.

3.

SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis.

Tyryshkin A, Bhattacharya A, Eissa NT.

Cancer Res. 2014 Apr 1;74(7):1996-2005. doi: 10.1158/0008-5472.CAN-13-1256.

4.

TSC2 modulates cell adhesion and migration via integrin-α1β1.

Moir LM, Black JL, Krymskaya VP.

Am J Physiol Lung Cell Mol Physiol. 2012 Oct 15;303(8):L703-10. doi: 10.1152/ajplung.00414.2011. Epub 2012 Aug 24.

5.

p27kip1 protein levels reflect a nexus of oncogenic signaling during cell transformation.

Miller JP, Yeh N, Hofstetter CP, Keskin D, Goldstein AS, Koff A.

J Biol Chem. 2012 Jun 8;287(24):19775-85. doi: 10.1074/jbc.M112.361972. Epub 2012 Apr 17.

6.

Staying alive: metabolic adaptations to quiescence.

Valcourt JR, Lemons JM, Haley EM, Kojima M, Demuren OO, Coller HA.

Cell Cycle. 2012 May 1;11(9):1680-96. doi: 10.4161/cc.19879. Epub 2012 May 1. Review.

7.

ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Cohen JD, Gard JM, Nagle RB, Dietrich JD, Monks TJ, Lau SS.

Toxicol Sci. 2011 Nov;124(1):75-87. doi: 10.1093/toxsci/kfr203. Epub 2011 Aug 2.

8.

Rho-associated kinase connects a cell cycle-controlling anchorage signal to the mammalian target of rapamycin pathway.

Park JH, Arakawa-Takeuchi S, Jinno S, Okayama H.

J Biol Chem. 2011 Jul 1;286(26):23132-41. doi: 10.1074/jbc.M110.209114. Epub 2011 May 11.

9.

Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

McDaniel SS, Wong M.

Neurosci Lett. 2011 Jun 27;497(3):231-9. doi: 10.1016/j.neulet.2011.02.037. Epub 2011 Feb 24. Review.

10.

Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?

Zeng LH, McDaniel S, Rensing NR, Wong M.

Cell Cycle. 2010 Jun 15;9(12):2281-5. Epub 2010 Jun 15.

11.

Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis.

Terasaki Y, Yahiro K, Pacheco-Rodriguez G, Steagall WK, Stylianou MP, Evans JF, Walker AM, Moss J.

Am J Respir Crit Care Med. 2010 Aug 15;182(4):531-9. doi: 10.1164/rccm.200911-1737OC. Epub 2010 Apr 22.

12.

Lymphangioleiomyomatosis and TSC2-/- cells.

Darling TN, Pacheco-Rodriguez G, Gorio A, Lesma E, Walker C, Moss J.

Lymphat Res Biol. 2010 Mar;8(1):59-69. doi: 10.1089/lrb.2009.0031. Review.

13.

AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability.

Short JD, Dere R, Houston KD, Cai SL, Kim J, Bergeron JM, Shen J, Liang J, Bedford MT, Mills GB, Walker CL.

Mol Carcinog. 2010 May;49(5):429-39. doi: 10.1002/mc.20613.

14.

Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.

Wong M.

Epilepsia. 2010 Jan;51(1):27-36. doi: 10.1111/j.1528-1167.2009.02341.x. Epub 2009 Oct 8. Review.

15.

Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression.

Kim SH, Miller FR, Tait L, Zheng J, Novak RF.

Int J Cancer. 2009 Jun 15;124(12):2813-28. doi: 10.1002/ijc.24278.

16.

AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.

Short JD, Houston KD, Dere R, Cai SL, Kim J, Johnson CL, Broaddus RR, Shen J, Miyamoto S, Tamanoi F, Kwiatkowski D, Mills GB, Walker CL.

Cancer Res. 2008 Aug 15;68(16):6496-506. doi: 10.1158/0008-5472.CAN-07-5756.

17.

cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner.

Smith EM, Proud CG.

EMBO J. 2008 Apr 9;27(7):1005-16. doi: 10.1038/emboj.2008.39. Epub 2008 Mar 13.

18.
19.

Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.

Goncharova EA, Goncharov DA, Lim PN, Noonan D, Krymskaya VP.

Am J Respir Cell Mol Biol. 2006 Apr;34(4):473-80. Epub 2005 Dec 30.

20.

MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.

Li S, Takeuchi F, Wang JA, Fuller C, Pacheco-Rodriguez G, Moss J, Darling TN.

J Exp Med. 2005 Sep 5;202(5):617-24. Epub 2005 Aug 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk